farmakoekonomicheskiy analiz "stoimost'-poleznost'" kak kriteriy ekonomicheskoy obosnovannosti ispol'zovaniya byudzhetnykh sredstv v onkologii
Clicks: 357
ID: 131133
2001
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
81.2
/100
357 views
260 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #2 of 20 articles by views in acta histochemica supplementband
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
В настоящее время в онкологии, как и в других отраслях медицины, врачи должны заботиться не только об увеличении продолжительности жизни, но и об улучшении ее качества, поэтому при оценке эффективности лечения необходимо учитывать его влияние как на выживаемость, так и на качество жизни. Для этого используется метод фармакоэкономического анализа "стоимость-полезность".
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (1 words).
Try re-searching for a better abstract.
| Reference Key |
poddubnaya2001farmakoekonomicheskiy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;I V Poddubnaya;T V Arkad'eva;I S Davidenko;L A Rozenbaum |
| Journal | acta histochemica supplementband |
| Year | 2001 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.